Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Buy
7,484
+92
+1% +$31.5K 0.53% 28
2026
Q1
$2.6M Sell
7,392
-64
-0.9% -$22.8K 0.58% 31
2025
Q4
$2.44M Hold
7,456
– – 0.54% 27
2025
Q3
$2.1M Buy
7,456
+162
+2% +$47K 0.47% 33
2025
Q2
$2.04M Buy
7,294
+174
+2% +$49.3K 0.49% 30
2025
Q1
$2.22M Sell
7,120
-8
-0.1% -$2.36K 0.58% 26
2024
Q4
$1.86M Buy
7,128
+109
+2% +$32.3K 0.47% 36
2024
Q3
$2.26M Sell
7,019
-2
-0% -$654 0.57% 27
2024
Q2
$2.19M Buy
7,021
+102
+1% +$30K 0.59% 30
2024
Q1
$1.97M Buy
6,919
+138
+2% +$40.4K 0.54% 32
2023
Q4
$1.95M Buy
6,781
+167
+3% +$45.5K 0.61% 23
2023
Q3
$1.78M Buy
6,614
+221
+3% +$55.2K 0.62% 20
2023
Q2
$1.42M Buy
6,393
+399
+7% +$92.6K 0.48% 35
2023
Q1
$1.45M Buy
5,994
+594
+11% +$146K 0.5% 29
2022
Q4
$1.42M Buy
5,400
+195
+4% +$52.3K 0.52% 25
2022
Q3
$1.17M Buy
5,205
+407
+8% +$98.7K 0.5% 31
2022
Q2
$1.17M Buy
4,798
+194
+4% +$47.5K 0.48% 30
2022
Q1
$1.11M Buy
4,604
+167
+4% +$38.4K 0.45% 35
2021
Q4
$1.02M Buy
4,437
+525
+13% +$111K 0.4% 35
2021
Q3
$809K Buy
+3,912
New +$900K 0.34% 49
2021
Q2
– Sell
-3,563
Closed -$874K – 49
2021
Q1
$874K Buy
3,563
+188
+6% +$44.9K 0.38% 40
2020
Q4
$800K Buy
+3,375
New +$778K 0.4% 38

Other funds holding AMGN

IAM Advisory's AMGN Position: Q2 2026 in Review

IAM Advisory increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $31.5K and bringing the position to 7,484 shares worth $2.71M. The position accounts for 0.53% of the portfolio, ranked #28.

IAM Advisory first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. 3,165 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • IAM Advisory held 7,484 shares of Amgen worth $2.71M as of Q2 2026.
  • IAM Advisory bought 92 Amgen shares in Q2 2026, an estimated $31.5K.
  • Amgen made up 0.53% of IAM Advisory's portfolio in Q2 2026, its #28 holding.
  • IAM Advisory first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • 3,165 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on IAM Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.